Back to Search Start Over

Fixation Using Alternative Implants for the Treatment of Hip Fractures

Authors :
Sheila Sprague, PhD
Mohit Bhandari, MD, PhD, FRCSC
Sofia Bzovsky, MSc
Taryn Scott, MSW, MSc
Lehana Thabane, PhD
Diane Heels-Ansdell, MSc
Robert V. O’Toole, MD
Andrea Howe, BS
Greg E. Gaski, MD
Lauren C. Hill, BS, CCRC
Krista M. Brown, MS, CCRC
Darius Viskontas, MD
Mauri Zomar, CCRP
Gregory J. Della Rocca, MD, PhD, FACS
Gerard P. Slobogean, MD, MPH
FAITH-2 investigators
Source :
OTA International, Vol 3, Iss 2, p e66 (2020)
Publication Year :
2020
Publisher :
Wolters Kluwer, 2020.

Abstract

Abstract. Objectives:. To conduct a pilot trial for the Fixation using Alternative Implants for the Treatment of Hip Fractures (FAITH-2) protocol to assess feasibility of a definitive trial. Design:. Pilot trial. Setting:. Twenty-five clinical sites across North America and Australia were initiated, but enrolment occurred in only 15 North American sites. Patients/Participants:. Ninety-one randomized adults aged 18 to 60 years with a femoral neck fracture requiring surgical fixation. Intervention:. Eligible patients were randomized to receive surgical treatment (sliding hip screw or cancellous screws) AND nutritional supplementation (4000 IU of vitamin D or placebo) for 6 months postfracture. Main Outcome Measurements:. Feasibility outcomes included: clinical site initiation, participant enrolment rate, proportion of participants with complete 12-month follow-up, level of data quality, and rate of protocol adherence (number of randomization errors, crossovers between treatment groups, and daily supplementation adherence). Results:. Eighty-six of 91 participants randomized into the pilot trial from 15 North American hospitals were deemed eligible. Four of five primary feasibility criteria were not achieved as we were unable to initiate clinical sites outside of North America and Australia due to feasibility constraints, slow participant enrolment (60 participants recruited over 36 mo), low adherence with daily nutritional supplementation at the 6-week (72.1%), 3-month (60.5%), and 6-month (54.7%) follow-up visits, and a high loss to follow-up rate of 22.1% at 12 months. Conclusions:. Despite not meeting key feasibility criteria, we increased our knowledge on the logistics and anticipated barriers when conducting vitamin D supplementation trials in this trauma population, which can be used to inform the design and conduct of future trials on this topic.

Subjects

Subjects :
Orthopedic surgery
RD701-811

Details

Language :
English
ISSN :
25742167 and 00000000
Volume :
3
Issue :
2
Database :
Directory of Open Access Journals
Journal :
OTA International
Publication Type :
Academic Journal
Accession number :
edsdoj.5718d67051664e2897f297ce489584b0
Document Type :
article
Full Text :
https://doi.org/10.1097/OI9.0000000000000066